LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA FC-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS

The present invention is directed to novel targeted heterodimeric fusion proteins comprising an IL-15/IL-15Ra Fc-fusion protein and a LAG- 3 antibody fragment-Fc fusion protein. La présente invention concerne de nouvelles protéines de fusion hétérodimères ciblées comprenant une protéine de fusion Fc...

Full description

Saved in:
Bibliographic Details
Main Authors DESJARLAIS, John, SCHUBBERT, Suzanne, BERNETT, Matthew
Format Patent
LanguageEnglish
French
Published 12.10.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to novel targeted heterodimeric fusion proteins comprising an IL-15/IL-15Ra Fc-fusion protein and a LAG- 3 antibody fragment-Fc fusion protein. La présente invention concerne de nouvelles protéines de fusion hétérodimères ciblées comprenant une protéine de fusion Fc d'IL-15/IL-15Ra et une protéine de fusion de fragment-Fc d'anticorps LAG-3.
Bibliography:Application Number: WO2023US65439